(Japanese)
(Japanese)
(Japanese)
 |  |  |  |
|---|
Dramatically
Accelerating
Infectious Disease Research.
Our MPV* and Mylc** cells, produced with regenerative medicine technologies, will solve the shortage of experimental cells for researches on malaria and other infectious diseases, and help researchers accelerate their experiments exponentially.
* We are now providing test
and pilot products and will
start full-scale production in 2020.
** We start to sell this product from 12th Dec in 2019.
NEWS RELEASE
Aug 19 ,2020
Aug 19 ,2020
MiCAN will support as a sponsor in JITMM Virtual 2020.
June 16 ,2020
We'll present the functional analysis of myeloid linage cell (Mylc cell) at poster session III in ISSCR 2020.
PRODUCT Video
動画を見る
PRODUCT LINE-UP
Mpv
immature
red blood-like cells for
Malaria (P.vivax)
research
Mylc
special
myeloid lineage cells for
Dengue and other infectious diseases
